Protein Disulfide Isomerase Interacts with Tau Protein and Inhibits Its Fibrillization

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Xu, Li Rong ^a   Liu, Xiao Ling ^a   Chen, Jie ^a   Liang, Yi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DISULFIDE ISOMERASE; RNA; TAU PROTEIN; THIOFLAVINE; THIOREDOXIN INTERACTING PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING ASSAY; CONFOCAL LASER MICROSCOPY; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IONIC STRENGTH; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR MECHANICS; NEUROBLASTOMA CELL; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FIBRILLIZATION; PROTEIN PROTEIN INTERACTION; RNA TRANSLATION; THERMODYNAMICS; TRANSMISSION ELECTRON MICROSCOPY;

BINDING SITES; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; HUMANS; KINETICS; NEURONS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN DISULFIDE-ISOMERASES; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; TAU PROTEINS; THERMODYNAMICS; THIAZOLES;

EID: 84884894382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076657     Document Type: Article

References (68)

1. Kuret J, Chirita CN, Congdon EE, Kannanayakal T, Li G, et al. (2005) Pathways of Tau fibrillization. Biochim Biophys Acta 1739: 167-178.
2. Goedert M, Spillantini MG, (2006) A century of Alzheimer's disease. Science 314: 777-781.
3. Ballatore C, Lee VM, Trojanowski JQ, (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8: 663-672.
4. Mo ZY, Zhu YZ, Zhu HL, Fan JB, Chen J, et al. (2009) Low micromolar zinc accelerates the fibrillization of human Tau via bridging of Cys-291 and Cys-322. J Biol Chem 284: 34648-34657.
5. Morris M, Maeda S, Vossel K, Mucke L, (2011) The many faces of Tau. Neuron 70: 410-426.
6. Patterson KR, Ward SM, Combs B, Voss K, Kanaan NM, et al. (2011) Heat shock protein 70 prevents both Tau aggregation and the inhibitory effects of preexisting Tau aggregates on fast axonal transport. Biochemistry 50: 10300-10310.
7. Voss K, Combs B, Patterson KR, Binder LI, Gamblin TC, (2012) Hsp70 alters Tau function and aggregation in an isoform specific manner. Biochemistry 51: 888-898.
8. Mandelkow EM, Mandelkow E, (2012) Biochemistry and cell biology of Tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med 2: a006247.
9. Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E, (1994) Structural studies of Tau protein and Alzheimer paired helical filaments show no evidence for β-structure. J Biol Chem 269: 24290-24297.
10. Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, et al. (2009) Structural polymorphism of 441-residue Tau at single residue resolution. PLoS Biol 7: e34.
11. Rosenberg KJ, Ross JL, Feinstein HE, Feinstein SC, Israelachvili J, (2008) Complementary dimerization of microtubule-associated Tau protein: Implications for microtubule bundling and Tau-mediated pathogenesis. Proc Natl Acad Sci USA 105: 7445-7450.
12. Zhu HL, Fernandez C, Fan JB, Shewmaker F, Chen J, et al. (2010) Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated Tau filament formation. J Biol Chem 285: 3592-3599.
13. Zhu HL, Meng SR, Fan JB, Chen J, Liang Y, (2011) Fibrillization of human Tau is accelerated by exposure to lead via interaction with His-330 and His-362. PLoS One 6: e25020.
14. Ma Q, Fan JB, Zhou Z, Zhou BR, Meng SR, et al. (2012) The contrasting effect of macromolecular crowding on amyloid fibril formation. PLoS One 7: e36288.
15. Meng SR, Zhu YZ, Guo T, Liu XL, Chen J, et al. (2012) Fibril-forming motifs are essential and sufficient for the fibrillization of human Tau. PLoS One 7: e38903.
16. Friedhoff P, von Bergen M, Mandelkow EM, Davies P, Mandelkow E, (1998) A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci USA 95: 15712-15717.
17. Schroder M, (2008) Endoplasmic reticulum stress responses. Cell Mol Life Sci 65: 862-894.
18. Kaufman RJ, (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13: 1211-1233.
19. Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, et al. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105: 891-902.
20. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, et al. (2006) S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517.
21. Wang CC, Tsou CL, (1993) Protein disulfide isomerase is both an enzyme and a chaperone. FASEB J 7: 1515-1517.
22. Noiva R, Lennarz WJ, (1992) Protein disulfide isomerase. A multifunctional protein resident in the lumen of the endoplasmic reticulum. J Biol Chem 267: 3553-3556.
23. Andreu CI, Woehlbier U, Torres M, Hetz C (2012) Protein disulfide isomerases in neurodegeneration: from disease mechanisms to biomedical applications. FEBS Lett 586, 2826-2834.
24. Freedman RB, Gane PJ, Hawkins HC, Hlodan R, McLaughlin SH, et al. (1998) Experimental and theoretical analyses of the domain architecture of mammalian protein disulphide-isomerase. Biol Chem 379: 321-328.
25. Alanen HI, Salo KE, Pekkala M, Siekkinen HM, Pirneskoski A, et al. (2003) Defining the domain boundaries of the human protein disulfide isomerases. Antioxid Redox Signal 5: 367-374.
26. Pirneskoski A, Klappa P, Lobell M, Williamson RA, Byrne L, et al. (2004) Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J Biol Chem 279: 10374-10381.
27. Wang C, Li W, Ren J, Fang J, Ke H, et al. (2013) Structural insights into the redox-regulated dynamic conformations of human protein disulfide isomerase. Antioxid Redox Signal 19: 36-45.
28. Darby NJ, Creighton TE, (1995) Characterization of the active site cysteine residues of the thioredoxin-like domains of protein disulfide isomerase. Biochemistry 34: 16770-16780.
29. Freedman RB, Klappa P, Ruddock LW, (2002) Protein disulfide isomerases exploit synergy between catalytic and specific binding domains. EMBO Rep 3: 136-140.
30. Klappa P, Ruddock LW, Darby NJ, Freedman RB, (1998) The b' domain provides the principal peptide-binding site of protein disulfide isomerase but all domains contribute to binding of misfolded proteins. EMBO J 17: 927-935.
31. Wang C, Chen S, Wang X, Wang L, Wallis AK, et al. (2010) Plasticity of human protein disulfide isomerase: evidence for mobility around the x-linker region and its functional significance. J Biol Chem 285: 26788-26797.
32. Hoffstrom BG, Kaplan A, Letso R, Schmid RS, Turmel GJ, et al. (2010) Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins. Nat Chem Biol 6: 900-906.
33. Walker AK, Farg MA, Bye CR, McLean CA, Horne MK, et al. (2010) Protein disulphide isomerase protects against protein aggregation and is S-nitrosylated in amyotrophic lateral sclerosis. Brain 133: 105-116.
34. Honjo Y, Ito H, Horibe T, Takahashi R, Kawakami K, (2010) Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease. Brain Res 1349: 90-96.
35. Honjo Y, Ito H, Horibe T, Shimada H, Nakanishi A, et al. (2012) Derlin-1-immunopositive inclusions in patients with Alzheimer's disease. Neuroreport 23: 611-615.
36. Barghorn S, Biernat J, Mandelkow E, (2005) Purification of recombinant Tau protein and preparation of Alzheimer-paired helical filaments in vitro. Methods Mol Biol 299: 35-51.
37. Alanen HI, Williamson RA, Howard MJ, Lappi AK, Jantti HP, et al. (2003) Functional characterization of ERp18, a new endoplasmic reticulum-located thioredoxin superfamily member. J Biol Chem 278: 28912-28920.
38. Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, et al. (2008) Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci USA 105: 18663-18668.
39. Zhou Z, Fan JB, Zhu HL, Shewmaker F, Yan X, et al. (2009) Crowded cell-like environment accelerates the nucleation step of amyloidogenic protein misfolding. J Biol Chem 284: 30148-30158.
40. Zhou Z, Yan X, Pan K, Chen J, Xie ZS, et al. (2011) Fibril formation of the rabbit/human/bovine prion proteins. Biophys J 101: 1483-1492.
41. Arrasate M, Pérez M, Avila J, (2000) Tau dephosphorylation at tau-1 site correlates with its association to cell membrane. Neurochem Res 25: 43-50.
42. Uberti D, Rizzini C, Spano PF, Memo M, (1997) Characterization of Tau proteins in human neuroblastoma SH-SY5Y cell line. Neurosci Lett 235: 149-153.
43. Liang Y, Du F, Sanglier S, Zhou BR, Xia Y, et al. (2003) Unfolding of rabbit muscle creatine kinase induced by acid. A study using electrospray ionization mass spectrometry, isothermal titration calorimetry, and fluorescence spectroscopy. J Biol Chem 278: 30098-30105.
44. Koivunen P, Pirneskoski A, Karvonen P, Ljung J, Helaakoski T, et al. (1999) The acidic C-terminal domain of protein disulfide isomerase is not critical for the enzyme subunit function or for the chaperone or disulfide isomerase activities of the polypeptide. EMBO J 18: 65-74.
45. Zhou HX, Rivas G, Minton AP, (2008) Macromolecular crowding and confinement: biochemical, biophysical, and potential physiological consequences. Annu Rev Biophys 37: 375-397.
46. Friedhoff P, von Bergen M, Mandelkow EM, Mandelkow E, (2000) Structure of Tau protein and assembly into paired helical filaments. Biochim Biophys Acta 1502: 122-132.
47. Barghorn S, Mandelkow E, (2002) Toward a unified scheme for the aggregation of Tau into Alzheimer paired helical filaments. Biochemistry 41: 14885-14896.
48. Chirita CN, Kuret J, (2004) Evidence for an intermediate in Tau filament formation. Biochemistry 43: 1704-1714.
49. Congdon EE, Kim S, Bonchak J, Songrug T, Matzavinos A, et al. (2008) Nucleation-dependent Tau filament formation: the importance of dimerization and an estimation of elementary rate constants. J Biol Chem 283: 13806-13816.
50. Goedert M, (1993) Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16: 460-465.
51. Wickner S, Maurizi MR, Gottesman S, (1999) Posttranslational quality control: folding, refolding, and degrading proteins. Science 286: 1888-1893.
52. Lee SJ, Desplats P, Sigurdson C, Tsigelny I, Masliah E, (2010) Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 6: 702-706.
53. Hu BR, Martone ME, Jones YZ, Liu CL, (2000) Protein aggregation after transient cerebral ischemia. J Neurosci 20: 3191-3199.
54. Matus S, Glimcher LH, Hetz C, (2011) Protein folding stress in neurodegenerative diseases: a glimpse into the ER. Curr Opin Cell Biol 23: 239-252.
55. Hetz C, (2012) The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 13: 89-102.
56. Ko HS, Uehara T, Nomura Y, (2002) Role of ubiquilin associated with protein-disulfide isomerase in the endoplasmic reticulum in stress-induced apoptotic cell death. J Biol Chem 277: 35386-35392.
57. Tanaka S, Uehara T, Nomura Y, (2000) Up-regulation of protein-disulfide isomerase in response to hypoxia/brain ischemia and its protective effect against apoptotic cell death. J Biol Chem 275: 10388-10393.
58. Conn KJ, Gao W, McKee A, Lan MS, Ullman MD, et al. (2004) Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology. Brain Res 1022: 164-172.
59. Atkin JD, Farg MA, Walker AK, McLean C, Tomas D, et al. (2008) Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis 30: 400-407.
60. Hetz C, Russelakis-Carneiro M, Walchli S, Carboni S, Vial-Knecht E, et al. (2005) The disulfide isomerase Grp58 is a protective factor against prion neurotoxicity. J Neurosci 25: 2793-2802.
61. Watts JC, Huo H, Bai Y, Ehsani S, Jeon AH, et al. (2009) Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathog 5: e1000608.
62. Cheng H, Wang L, Wang CC, (2010) Domain a' of protein disulfide isomerase plays key role in inhibiting α-synuclein fibril formation. Cell Stress Chaperones 15: 415-421.
63. Erickson RR, Dunning LM, Olson DA, Cohen SJ, Davis AT, et al. (2005) In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind β-amyloid. Biochem Biophys Res Commun 332: 50-57.
64. Farg MA, Soo KY, Walker AK, Pham H, Orian J, et al. (2012) Mutant FUS induces endoplasmic reticulum stress in amyotrophic lateral sclerosis and interacts with protein disulfide-isomerase. Neurobiol Aging 33: 2855-2868.
65. Darby NJ, Creighton TE, (1995) Functional properties of the individual thioredoxin-like domains of protein disulfide isomerase. Biochemistry 34: 11725-11735.
66. Kosuri P, Alegre-Cebollada J, Feng J, Kaplan A, Ingles-Prieto A, et al. (2012) Protein folding drives disulfide formation. Cell 151: 794-806.
67. Tian G, Kober FX, Lewandrowski U, Sickmann A, Lennarz WJ, et al. (2008) The catalytic activity of protein-disulfide isomerase requires a conformationally flexible molecule. J Biol Chem 283: 33630-33640.
68. DeSantis ME, Leung EH, Sweeny EA, Jackrel ME, Cushman-Nick M, et al. (2012) Operational plasticity enables Hsp104 to disaggregate diverse amyloid and nonamyloid clients. Cell 151: 778-793.